Lancet

Article	Citations
Donald Bernard Longmore	3905
Interpreting COVID-19 data from China: a call for caution	3606
Human rights considerations are key when choosing a conference location	2605
Establishing equitable partnerships between the Global North and Global South	2526
The acknowledgment of death	2220
Miriam Mutebi: transforming breast cancer care in Africa	2206
Tonsillectomy for recurrent tonsillitis: the NATTINA trial	2034
Merrill Singer	1749
The injustice of tuberculosis	1663
Atosiban and managing women in preterm labour	1646
Political courage needed to prevent the next pandemic	1305
Hearing intervention and cognitive decline: the ACHIEVE trial	1257
Thinking outside of the tin box	1100
From disappointment to despair: USAID cuts to Myanmar's HIV services	1044
Hypochondria, the ghost at medicine's feast	964
May Edward Chinn: pioneer of early cancer detection	951
Ronald Duncan Bradley	932
Israel border closure denying health care to Gazans	909
Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement	881
On the quantification of military violence in Gaza	822
Pandemics and the tourism industry: who is in control?	819
Calvarium indentations in multiple myeloma and CAR T-cell therapy	814
Nafis Sadik	812
Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm	811
Offline: What have we done to medical students?	798

Prominent skin folds of the scalp provide a superficial clue in acromegaly	794
Nigeria: health as a political prerequisite	770
Visa bureaucracy causing GPs to leave the UK	732
A fair day's wage for a fair day's work	708
Offline: Changing the argument for health	702
Anatomy teaching, dissection, and dignity of the dead	689
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial	686
Threat level in the Gaza Strip: fatalities per 1000 person-years	682
Imagining alternative paths for WHO 75 years in	680
Remote haemodynamic monitoring in patients with heart failure – Authors' reply	673
Gaining MOMENTUM against anaemic myelofibrosis	665
Routine immunisations: reversing the decline	659
Human rights and health: a story of justice, hope, and resilience	641
Ophira Ginsburg: educating and empowering women with cancer	613
Lowitja O'Donoghue	605
Associations between parental smoking and teenage alcohol and drug use in the Growing Up in Ireland cohort study: a longitudinal observational study	603
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – Authors' reply	600
Treatment of vulnerable atherosclerotic plaques: the PREVENT trial	597
Türkiye rocked by newborn care scandal	582
Childhood epilepsy	571
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial	570
A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance	563
An age of uncertainty: mental health in young people	554
Visualising facial distortions in prosopometamorphopsia	549
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?	545
Mpox: the need for a coordinated international response	540
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial	528
Resurgence of cholera amidst ongoing war in Sudan	517
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial	511
The 2024 Lasker Awards	510
Tackling heroin use in Mozambique	505
“I'm losing faith in everything”: a qualitative study to understand barriers to accessing suitable mental health support for children and young people in Wales	505
CAR T-cell perspectives in lupus – Authors' reply	505
Lower respiratory tract infections in early childhood	501
A decolonised Commission agenda: the missing ingredients	499
Protecting children from racism: urgent health system actions	493
Health at stake in Kenya elections	492
The Peer Education Project to improve mental health literacy in secondary school students in England: a qualitative realist evaluation	487
Key questions regarding the SYMPLICITY HTN-3 trial	475
Sackler money to go towards reducing overdose deaths	469
床前孝子	461
Anna Gilmore: confronting the commercial determinants of health	457
Anthony Bryceson	455
Offline: “I have no place to go”	455
Annabel Sowemimo: countering inequities in health care	449
US plan to shield science from “inappropriate influence”	448
Perilous two-tier COVID-19 global vaccine roll-out	447
Orbital atherectomy for stent implantation: the ECLIPSE trial – Authors' reply	445
Use the remaining carbon budget wisely for health equity and climate justice	435
Protein provision during critical illness	429

The road ahead for immediate kangaroo mother care in resource-constrained health systems	429
WHO EMRO's initiative on economic sanctions: delayed but promising	425
TRiP(cast) score and thrombosis risk for lower limb immobilisation – Authors' reply	424
Natural or artificial menstrual cycle for frozen embryo transfer	423
To keep health as a unifying force, we must put resources into tackling health misinformation and disinformation	416
An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial	413
Department of Error	406
Department of Error	405
Department of Error	402
Department of Error	399
Retraction: The first tissue-engineered airway transplantation: 5-year follow-up results	393
Department of Error	391
Department of Error	383
Beverly Malone: valuing diversity in nursing	380
Increasing humanitarian concerns for 2023	375
Does TRIANGLE take down transplantation in mantle cell lymphoma?	374
Moving past the COVID-19 emergency in the USA	371
Impact of anti-immigration measures on health	362
Department of Error	360
Tom Beauchamp	354
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi	354
A taste of your own medicine: the experience of a transplant	353
Prioritising maternal health must include care before pregnancy	349
Iscalimab 600 mg: justified or excessive? – Authors' reply	349
Offline: The death of globalism (part 2)	346
Strikes	341
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial – Authors' reply	338
Can the FDA fulfil its mission with a smaller workforce?	336
Moderna stalls on African vaccine manufacturing plans	336
Implementation of adaptation to climate change in public health in Europe: qualitative thematic analysis	332
South Korean doctors threaten mass resignation	331
Pembrolizumab for locally advanced cervical cancer	330
Colonoscopy versus faecal immunochemical testing in COLONPREV	328
Offline: Meditations of melancholy	327
Immediate versus delayed sequential bilateral cataract surgery	326
Nigeria's National Mental Health Act 2021: any challenges ahead?	326
Offline: Political declarations—clichés and lies	326
Primary health care on the ballot in Australian election	325
A new era for Africa CDC	323
Hypertrophic cardiomyopathy secondary to hydroxychloroquine toxicity in a patient with rheumatoid arthritis	323
High-dose dual-antibiotic loaded bone cement in patients undergoing hemiarthroplasty	321
Australia to introduce sweeping e-cigarette regulations	318
Realising transformative change in adolescent health and wellbeing: a second Lancet Commission	317
Changing gloves and switching instruments to decrease surgical site infection in abdominal surgery	307
Morphine for Gaza? Limits of care during genocidal violence	306
Knowledge and attitudes towards organ donation among students at An-Najah National University: a cross-sectional study	304
Legal accountability for climate change	303
Offline: The unavoidable reckoning	300
Malaria vaccines: a test for global health	296
Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use	295
Mortality during migration through the Darién Gap in Panama in 2018–22	295
A new drug for rare diseases: pozelimab for CHAPLE disease	294
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind	291
Uniting academies of medicine on climate and health	288
The rise of China's research: a global opportunity	287
Pivotal points in the science of dementia risk reduction	284
Mpox in Kenya	283
The dawn of immunotherapy in mismatch repair proficient colorectal cancer	279
Treatment of MSSA bacteraemia: a call for a personalised approach	279
Regional action needed to halt antimalarial drug resistance in Africa	278
Health care under Milei	277
Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts	276
Preventing cancer: the only way forward	271
Primary health-care practices for deaf children should include early incorporation of a signed language	271
Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets	270
HPV vaccination and cervical cancer screening	268
IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinoma	268
Fluid retention and heart failure in the PRECISION trial – Authors' reply	267
Why Ukraine's energy insecurity is a maternal health crisis	265
“It's not about us anymore”: after the Le Scouarnec case	264
Peace: more than an end to war	263
How can engagement with political science and international relations for health be improved?	263
Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review	256
Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation	255
The health dimensions of violence in Palestine: a call to prevent genocide	254
Refiloe Masekela: building access to care for childhood lung disease	253
Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial	253
Politicised threats to science endanger global health and humanity	250
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial	250
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trial	248

Sanctions and the right to health in post-Assad Syria	246
Improving children's lives—the case for universality	245
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials	244
COVID-19 mRNA vaccination and myocarditis or pericarditis	244
Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlle	242
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial	242
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, random	242
Brazil to start widespread dengue vaccinations	240
From innovation to impact in cardiovascular disease	239
Racial inequities in homicide rates: Black women in the USA	236
Department of Error	235
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis	235
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches	234
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes	232
The pathogenesis of Parkinson's disease	231
Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial	229
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China	226
Deaths potentially averted by small changes in physical activity and sedentary time: an individual participant data meta-analysis of prospective cohort studies	223
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Bur	222
Haemophilia	222
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised control	222
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study	221
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study	221
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)	221
Autosomal dominant polycystic kidney disease	220
Shakuntala Thilsted: shifting our approach to food systems	219
Public health and gun violence	219
Co-production of a stakeholder workshop to inform multimorbidity prevention research: working with public contributors to ask the right questions (the MELD-B experience)	218
Traditional Chinese medicine for acute intracerebral haemorrhage	218
Assessing adherence to Government's sugar, salt, and calorie reduction targets of the top 20 UK restaurants' menus in 2024: a cross-sectional study	218
Warnings over misuse of psychiatry in Russia	217
Opioids for back and neck pain: the OPAL trial	214
Recommitting to global solidarity: introducing the Kigali Call to Action	213
CAR T-cell therapy for patients with relapsed or refractory marginal zone lymphoma	213
Irrigation efficacy in CSDH surgery: the FINISH trial – Authors' reply	212
Accelerating progress towards gender equity in health and science	211
A programme for greater health equity for the next UK Government	211
The Health Index: a framework to guide health-driven prosperity	211
To what extent does time spent on social media influence adolescent use of cigarettes and e-cigarettes: a longitudinal analysis of the UK Millennium Cohort Study	208
Global HIV targets: a roadmap to 2030 and beyond	208
Warnings over the future of UK medical research	207
Naveen Thacker: immunisation advocate and paediatrics leader	206
Ticagrelor monotherapy for acute coronary syndromes – Authors' reply	206
Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab	206
Sparsentan and kidney protection: improved medullary oxygenation?	204
How do homeless service users view their own health and healthcare? An ethnographic study	204
Mechanical circulatory support for cardiogenic shock	203
Unanswered questions from the IRONMAN trial	201
Timing of cardiac surgery and anticoagulants after acute ischaemic stroke	201
Racism and the health system	200
Opening the door to widespread iPSC-derived regenerative therapy for corneal epithelial opacity	200
Optimal usage of antibacterial sutures for wound closure in clinical trials addressing SSI – Authors' response	200
Why aren't the Republicans talking about health?	200
Clopidogrel use in chronic coronary syndrome: a fragile lifelong choice	199
The USA and the plight of children in a humanitarian crisis	197
Accelerating domestic investments to end AIDS in Africa	196
Naegleria fowleri in Kerala, India: prevention over panic	196
Strengthening global snakebite data for WHO's goal for 2030	195
“Even worse than fentanyls”: nitazenes in the USA	195
Vesicular monoamine transport inhibitors: current uses and future directions	192
Offline: No dark sarcasm in the classroom	192
US Surgeon General: loneliness is a public health crisis	190
American chaos: standing up for health and medicine	189
Preventing drug resistance: combination treatment for mpox	188
The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19	188
Androgen deprivation therapy combined with postoperative radiotherapy for prostate cancer management	187
Private actors and governance for planetary health equity	184
Wolves and women's bodies	184
Efficacy of typhoid conjugate vaccine in Malawian children – Authors’ reply	183
Assessing worldwide trends of underweight and obesity – Authors' reply	182
Kangaroo mother care before stabilisation: the OMWaNA trial	182
Emodepside against hookworm	182
Offline: Help us, please	181
Libby Sallnow: the gentle disruptor	181
The nuclear threat: policy, science, and public opinion	180
Developing a vaccine against Marburg virus disease	179
Infectious diseases in 2025: a year for courage and conviction	177
The structural roots of violence against female health workers	177
Error in NHS England's BMI calculator and daily calorie recommendations	176
The R21/Matrix-M malaria vaccine: questions remain	176
Offline: “My brothers and sisters in Israel and Palestine”	175
Lowering LDL cholesterol in clinical practice: time for change?	175
Lower respiratory tract infections in early childhood	174
Eugene John Gangarosa	173
Rob Moodie: a radical voice in public health	171
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy	170
The Lancet's enduring legacy: speaking truth to power	170
Advancing outcomes of metastatic HER2-positive breast cancer	168
Gender inclusivity in India's National Family Health Survey	167
Where are the children and adolescents?	167
Should alcohol carry cancer warning labels?	166
Louis Pasteur's public engagement	165
Raj Panjabi: bringing a global outlook to the US pandemic response	165
Marceline Tutu van Furth: inspiring future medical leaders	162
Peter Waiswa: building better health systems in Africa and beyond	162